Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy

被引:235
作者
Pratcorona, Marta [1 ]
Brunet, Salut [2 ]
Nomdedeu, Josep [2 ]
Maria Ribera, Josep [3 ]
Tormo, Mar [4 ]
Duarte, Rafael [5 ]
Escoda, Lourdes [6 ]
Guardia, Ramon [7 ]
Queipo de Llano, M. Paz [8 ]
Salamero, Olga [9 ]
Bargay, Joan [10 ]
Pedro, Carmen [11 ]
Maria Marti, Josep [12 ]
Torrebadell, Montserrat [1 ]
Diaz-Beya, Marina [1 ]
Camos, Mireia [13 ]
Colomer, Dolors [1 ]
Hoyos, Montserrat [2 ]
Sierra, Jorge [2 ]
Esteve, Jordi [1 ]
机构
[1] Hosp Clin Barcelona, Dept Hematol, Inst Invest Biomed August Pi & Sunyer, E-08036 Barcelona, Spain
[2] Univ Autonoma Barcelona, Dept Hematol, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain
[3] Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Dept Hematol, Badalona, Spain
[4] Hosp Clin, Dept Hematol, Valencia, Spain
[5] Hosp Duran & Reynals, Dept Hematol, Lhospitalet De Llobregat, Spain
[6] Hosp Joan 23, Dept Hematol, Tarragona, Spain
[7] Hosp Josep Trueta, Dept Hematol, Girona, Spain
[8] Hosp Virgen de la Victoria, Dept Hematol, Malaga, Spain
[9] Hosp Valle De Hebron, Dept Hematol, Barcelona, Spain
[10] Hosp Son Llatzer, Dept Hematol, Palma De Mallorca, Spain
[11] Hosp del Mar, Dept Hematol, Barcelona, Spain
[12] Hosp Mutua de Terrassa, Dept Hematol, Terrassa, Spain
[13] Hosp St Joan de Deu, Dept Hematol, Esplugas de Llobregat, Spain
关键词
INTERNAL TANDEM DUPLICATION; ACUTE MYELOGENOUS LEUKEMIA; STEM-CELL TRANSPLANTATION; PROGNOSTIC IMPACT; DNMT3A MUTATIONS; GENE-MUTATIONS; ADULT PATIENTS; AML; LEVEL; PREVALENCE;
D O I
10.1182/blood-2012-06-431122
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Risk associated to FLT3 internal tandem duplication (FLT3-ITD) in patients with acute myeloid leukemia (AML) may depend on mutational burden and its interaction with other mutations. We analyzed the effect of FLT3-ITD/FLT3 wild-type (FLT3wt) ratio depending on NPM1 mutation (NPM1mut) in 303 patients with intermediate-risk cytogenetics AML treated with intensive chemotherapy. Among NPM1mut patients, FLT3wt and low ratio (<0.5) subgroups showed similar overall survival, relapse risk, and leukemia-free survival, whereas high ratio (>= 0.5) patients had a worse outcome. In NPM1wt AML, FLT3-ITD subgroups showed a comparable outcome, with higher risk of relapse and shortened overall survival than FLT3wt patients. Allogeneic stem cell transplantation in CR1 was associated with a reduced relapse risk in all molecular subgroups with the exception of NPM1mut AML with absent or low ratio FLT3-ITD. In conclusion, effect of FLT3 burden is modulated by NPM1 mutation, especially in patients with a low ratio. (Blood. 2013;121(14):2734-2738)
引用
收藏
页码:2734 / 2738
页数:5
相关论文
共 25 条
[1]   FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group [J].
Abu-Duhier, FM ;
Goodeve, AC ;
Wilson, GA ;
Gari, MA ;
Peake, IR ;
Rees, DC ;
Vandenberghe, EA ;
Winship, PR ;
Reilly, JT .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (01) :190-195
[2]   Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype [J].
Boissel, N ;
Renneville, A ;
Biggio, V ;
Philippe, N ;
Thomas, X ;
Cayuela, JM ;
Terre, C ;
Tigaud, I ;
Castaigne, S ;
Raffoux, E ;
De Botton, S ;
Fenaux, P ;
Dombret, H ;
Preudhomme, C .
BLOOD, 2005, 106 (10) :3618-3620
[3]   Improved outcome after stem-cell transplantation in FLT3/ITD-positive AML [J].
Bornhaeuser, Martin ;
Illmer, Thomas ;
Schaich, Markus ;
Soucek, Silke ;
Ehninger, Gerhard ;
Thiede, Christian .
BLOOD, 2007, 109 (05) :2264-2265
[4]   Impact of FLT3 Internal Tandem Duplication on the Outcome of Related and Unrelated Hematopoietic Transplantation for Adult Acute Myeloid Leukemia in First Remission: A Retrospective Analysis [J].
Brunet, Salut ;
Labopin, Myriam ;
Esteve, Jordi ;
Cornelissen, Jan ;
Socie, Gerard ;
Iori, Anna P. ;
Verdonck, Leo F. ;
Volin, Liisa ;
Gratwohl, Alois ;
Sierra, Jorge ;
Mohty, Mohamad ;
Rocha, Vanderson .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (07) :735-741
[5]   Prognostic impact of white blood cell count in intermediate risk acute myeloid leukemia: relevance of mutated NPM1 and FLT3-ITD [J].
de Jonge, Hendrik J. M. ;
Valk, Peter J. M. ;
de Bont, Eveline S. J. M. ;
Schuringa, Jan Jacob ;
Ossenkoppele, Gert ;
Vellenga, Edo ;
Huls, Gerwin .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (09) :1310-1317
[6]   Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics:: interaction with other gene mutations [J].
Döhner, K ;
Schlenk, RF ;
Habdank, M ;
Scholl, C ;
Rücker, FG ;
Corbacioglu, A ;
Bullinger, L ;
Fröhling, S ;
Döhner, H .
BLOOD, 2005, 106 (12) :3740-3746
[7]   Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group [J].
Gaidzik, Verena Ingeborg ;
Schlenk, Richard Friedrich ;
Moschny, Simone ;
Becker, Annegret ;
Bullinger, Lars ;
Corbacioglu, Andrea ;
Krauter, Juergen ;
Schlegelberger, Brigitte ;
Ganser, Arnold ;
Doehner, Hartmut ;
Doehner, Konstanze .
BLOOD, 2009, 113 (19) :4505-4511
[8]   No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML 10 and 12 trials [J].
Gale, RE ;
Hills, R ;
Kottaridis, PD ;
Srirangan, S ;
Wheatley, K ;
Burnett, AK ;
Linch, DC .
BLOOD, 2005, 106 (10) :3658-3665
[9]   The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia [J].
Gale, Rosemary E. ;
Green, Claire ;
Allen, Christopher ;
Mead, Adam J. ;
Burnett, Alan K. ;
Hils, Robert K. ;
Linch, David C. .
BLOOD, 2008, 111 (05) :2776-2784
[10]   Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials [J].
Grimwade, David ;
Hills, Robert K. ;
Moorman, Anthony V. ;
Walker, Helen ;
Chatters, Stephen ;
Goldstone, Anthony H. ;
Wheatley, Keith ;
Harrison, Christine J. ;
Burnett, Alan K. .
BLOOD, 2010, 116 (03) :354-365